Day: June 26, 2025

MARKET.live To Broadcast Exclusive BelliWelli Event on Walmart.com LAS VEGAS, June 26, 2025 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the “Company”), Transforming the Landscape of Social Commerce, Social Telehealth and Social Crowdfunding with MARKET.live; VANITYPrescribed; GoodGirlRx; and the GO FUND YOURSELF TV Show, today announced its MARKET.live division will produce and host a high-profile Walmart livestream shopping event for gut-health brand BelliWelli. The exclusive livestream will air on Walmart.com on Tuesday, July 1, 2025, at 4:00 PM PT, marking BelliWelli’s debut on the platform. The event will be broadcast live from MARKET.live Studios in Los Alamitos, California, utilizing MARKET’s full-service technical production team to deliver a premium livestream shopping...

Shareholders urged to confirm eligibility and submit documentation if shares are held in street name NEWPORT BEACH, Calif., June 26, 2025 (GLOBE NEWSWIRE) — GivBux, Inc. (OTC: GBUX), a publicly traded Super App and charitable giving platform, today confirmed that the special 1-for-10 warrant dividend previously approved by its Board of Directors will be distributed to shareholders on Monday, July 7, 2025. Although the official payable date is July 5, the distribution will occur on Monday, July 7, as July 5 falls on a Saturday. The Board of Directors has confirmed that the dividend will consist of warrants issued on a 1-for-10 basis, granting shareholders the right to purchase one share of GivBux common stock for every 10 shares owned. Each warrant will be exercisable at $4.00 per share, subject to the terms and conditions outlined...

Wuxi, China, June 26, 2025 (GLOBE NEWSWIRE) — HUHUTECH International Group Inc. (Nasdaq: HUHU) (the “Company” or “HUHUTECH”), a professional provider of factory facility management and monitoring systems, today announced that on March 7, 2025, it entered into a share purchase agreement (the “Agreement”) with Mr. Zhi Zhang to acquire 100% of the issued equity interests of Huhu Technologies Deutschland GmbH (“Huhu Deutschland”). This acquisition is a part of the Company’s global growth strategy to establish HUHUTECH’s presence in the European market for high-purity gas and chemical production systems in the semiconductor industry. The acquisition was completed on May 7, 2025. Pursuant to the Agreement, HUHUTECH agreed to acquire 100% of the equity interests of Huhu Deutschland from its sole shareholder, Mr. Zhi Zhang, for a total...

CONCORD, Ontario, June 26, 2025 (GLOBE NEWSWIRE) — Ultrack Systems Inc. (OTC: MJLB) is excited to announce the official launch of PUR Rx, a next-generation digital health platform formed through a 50/50 joint venture with Synergy Health Rx Corp. Designed to transform how Canadians access prescribed therapies, PUR Rx merges digital innovation with trusted medical infrastructure to deliver patient-first care at scale. With the market for digital health in Canada expected to exceed CAD $4.7 billion by 2026 (Statista) and showing compound annual growth of 8.3%, PUR Rx arrives at a pivotal moment. The platform is poised to capture significant share in a sector driven by virtual care, streamlined prescriptions, and personalized healthcare delivery. “PUR Rx is more than a joint venture—it’s a bold leap forward into the future of digital...

New episode spotlights the severe burden of Netherton Syndrome in infants and children, reinforcing the need for effective pediatric treatments ASHBURN, Va., June 26, 2025 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced the release of a new episode in its NETHERTON NOW video series. The episode features Professor Jemima Mellerio, a recognized authority in dermatology and genetic skin disorders. In the video, Professor Mellerio, Consultant Dermatologist at St John’s Institute of Dermatology at Guy’s and St Thomas’ NHS Foundation Trust and Honorary Chair of Paediatric Dermatology at King’s College London, shares her perspective on the complex and life-threatening challenges of Netherton...

Collaboration with French MedTech company, TISSIUM, has resulted in FDA approval for unique 3D-printed polymeric solution for repair of peripheral nerve damage 3D Systems’ bioprinting system enabled production of a 3D-printed bioabsorbable medical device leveraging TISSIUM’s proprietary biomorphic programable polymers—a major industry milestone that sets new standard for high resolution elastomeric 3D-printed medical implants Builds on 3D Systems’ pioneering work to develop additive manufacturing solutions for regenerative medicine applications 3D Systems’ solutions accelerating additive manufacturing use in bioprinting—total market anticipated to reach more than $2 billion by end of 2029ROCK HILL, South Carolina, June 26, 2025 (GLOBE NEWSWIRE) — Today, 3D Systems (NYSE: DDD) announced that its 3D bioprinting technologies have...

Geneva, Switzerland, June 26, 2025 (GLOBE NEWSWIRE) — SEALSQ’s unique value proposition integrates PKI with Quantum-Resistant Cryptography and Post-Quantum Secure Hardware SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced expanded capabilities to support the rapidly evolving Internet of Medical Things (IoMT) landscape. SEALSQ’s technologies provide essential security components for applications that secure communications, authenticate devices, and enforce compliance with next-generation digital health frameworks.The IoMT represents a vast network of interconnected medical devices, sensors, software, and healthcare systems utilizing internet connectivity to...

Important Study Shows Vivos Technology to be a Safe and Highly Effective, Non-Surgical Alternative to Surgical Removal of Tonsils and Adenoids in Children LITTLETON, Colo., June 26, 2025 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leader in proprietary, non-invasive treatments for obstructive sleep apnea (OSA), today announced that the European Journal of Pediatrics has published the results of a groundbreaking multicenter clinical trial evidencing positive results for the treatment of OSA in children using Vivos’ patented Daytime-Nighttime Appliance (DNA). The study importantly noted that “This is the first study demonstrating that the [Vivos DNA] device is safe and efficacious in treating children with OSA.” In September 2024, Vivos received an unprecedented FDA 510(k) clearance for...

Spetner Reports 95% Revenue Growth and Tripled Net Income in Q1 2025, Highlighting Strong Profitability and Cash Flows Ahead of Planned Acquisition LAKEWOOD, NJ, June 26, 2025 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI) (“Reliance,” “we,” “us,” “our” or the “Company”) today highlighted the strong preliminary unaudited financial results of Spetner Associates, Inc. (“Spetner”) for the first quarter ended March 31, 2025. As previously announced, Reliance has entered into a definitive agreement to acquire Spetner, and the transaction continues to advance toward closing. Spetner’s Q1 2025 Financial Highlights (Unaudited):Revenue increased by more than 95% year-over-year to approximately $5.16 million, compared with $2.64 million in Q1 2024. Operating income margin grew by 29% year-over-year to 74% from 46% in Q1...

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) — via InvestorWire — LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 70+ brands within the Dynamic Brand Portfolio @ IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Near-Term Production Assets Gain Traction amid Historic Gold Price Surge,” please visit: https://ibn.fm/yr5Zp Gold’s remarkable surge — driven by an unstable U.S. fiscal policy and rising inflation — has propelled prices beyond the historic US$3,300 per ounce threshold in early 2025 and sparked even more bullish outlooks. Many experts are forecasting...